Breaking News Instant updates and real-time market news.

JUNO

Juno Therapeutics

$29.88

-1.56 (-4.96%)

14:00
11/23/16
11/23
14:00
11/23/16
14:00

Juno Therapeutics price target lowered to $34 from $39 at JPMorgan

JPMorgan analyst Cory Kasimov lowered his price target for Juno Therapeutics to $34 after the company voluntarily placed the JCAR015 pivotal ROCKET study on clinical hold. The analyst reiterates a Neural rating on the shares.

  • 23

    Nov

  • 03

    Dec

  • 03

    Dec

JUNO Juno Therapeutics
$29.88

-1.56 (-4.96%)

11/23/16
JANY
11/23/16
NO CHANGE
JANY
Weakness in bluebird bio unwarranted after Juno trial halt, says Janney Capital
11/23/16
11/23/16
NO CHANGE

Buy
bluebird bio weakness unwarranted after Juno trial halt, says Janney Capital
As previously reported, Janney Capital analyst Debjit Chattopadhyay said the weakness in bluebird bio (BLUE) is unwarranted on the heels of Juno's (JUNO) second clinical hold for JCAR015. Chattopadhyay notes several key differences between JCAR015 and bluebird's bb2121, including their targets, diseases, vectors, preconditioning regimens and others. He remains a buyer of bluebird ahead of a "potentially watershed ASH for its lentiglobin platform" and keeps a Buy rating on the stock.
11/23/16
PIPR
11/23/16
NO CHANGE
PIPR
Piper says CAR-T researchers must heed risks highlighted by Juno news
Piper Jaffray analyst Joshua Schimmer said the CAR-T field has "taken another step back" after Juno Therapeutics (JUNO) put a hold on its JCAR015 trial again due to fatal cerebral edema and cautioned companies exploring these therapies to be mindful of "unnecessarily aggressive development and under-appreciation of the potent and possibly highly toxic nature" of the approach. However, Schimmer expressed his confidence that companies he covers in the CAR-T space - namely bluebird bio (BLUE), Cellectis (CLLS), Celgene (CELG), Bellicum Pharmaceuticals (BLCM), Lion Biotechnologies (LBIO) and NantKwest (NK) - will "respect the power of these platforms and remember patients' lives are more important than stock prices."
11/23/16
FBRC
11/23/16
DOWNGRADE
FBRC
Market Perform
Juno Therapeutics downgraded to Market Perform from Outperform at FBR Capital

TODAY'S FREE FLY STORIES

AABA

Altaba

$66.59

-0.33 (-0.49%)

, BABA

Alibaba

$177.39

-0.56 (-0.31%)

05:52
09/22/17
09/22
05:52
09/22/17
05:52
Recommendations
Altaba, Alibaba, Yahoo Japan analyst commentary  »

Altaba price target…

AABA

Altaba

$66.59

-0.33 (-0.49%)

BABA

Alibaba

$177.39

-0.56 (-0.31%)

YAHOY

Yahoo Japan

$8.90

-0.08 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

REPYY

Repsol

$18.47

0.1 (0.54%)

05:52
09/22/17
09/22
05:52
09/22/17
05:52
Upgrade
Repsol rating change  »

Repsol upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSAR

Versartis

$21.60

-0.25 (-1.14%)

05:49
09/22/17
09/22
05:49
09/22/17
05:49
Downgrade
Versartis rating change  »

Versartis downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRPIF

BRP Inc.

05:48
09/22/17
09/22
05:48
09/22/17
05:48
Upgrade
BRP Inc. rating change  »

BRP Inc. upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$92.64

-1.76 (-1.86%)

05:47
09/22/17
09/22
05:47
09/22/17
05:47
Hot Stocks
Glass Lewis recommends Procter & Gamble holders vote for Nelson Peltz »

Trian Fund Management,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$12.27

-0.07 (-0.57%)

05:46
09/22/17
09/22
05:46
09/22/17
05:46
Recommendations
MiMedx analyst commentary  »

MiMedx shares offer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

BA

Boeing

$256.04

0.58 (0.23%)

05:45
09/22/17
09/22
05:45
09/22/17
05:45
Hot Stocks
Boeing sees growing demand for new airplanes in Southeast Asia »

Boeing projects a demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

05:45
09/22/17
09/22
05:45
09/22/17
05:45
General news
Breaking General news story  »

San Francisco Federal…

SSNI

Silver Spring

$16.15

0.01 (0.06%)

, ITRI

Itron

$75.85

-0.4 (-0.52%)

05:40
09/22/17
09/22
05:40
09/22/17
05:40
Downgrade
Silver Spring, Itron rating change  »

Silver Spring downgraded…

SSNI

Silver Spring

$16.15

0.01 (0.06%)

ITRI

Itron

$75.85

-0.4 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$41.62

-3.59 (-7.94%)

05:38
09/22/17
09/22
05:38
09/22/17
05:38
Syndicate
Juno Therapeutics 6.1M share Secondary priced at $41.00 »

Morgan Stanley and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 22

    Sep

AA

Alcoa

$46.25

-1.25 (-2.63%)

05:38
09/22/17
09/22
05:38
09/22/17
05:38
Downgrade
Alcoa rating change  »

Alcoa downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOBE

Bob Evans

$77.29

-0.2 (-0.26%)

, POST

Post Holdings

$86.97

-0.39 (-0.45%)

05:38
09/22/17
09/22
05:38
09/22/17
05:38
Downgrade
Bob Evans, Post Holdings rating change  »

Bob Evans downgraded to…

BOBE

Bob Evans

$77.29

-0.2 (-0.26%)

POST

Post Holdings

$86.97

-0.39 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$153.39

-2.68 (-1.72%)

05:36
09/22/17
09/22
05:36
09/22/17
05:36
Recommendations
Apple analyst commentary  »

Piper ups Apple target to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

TIF

Tiffany

$89.85

-0.08 (-0.09%)

05:31
09/22/17
09/22
05:31
09/22/17
05:31
Downgrade
Tiffany rating change  »

Tiffany downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

, VSAR

Versartis

$21.60

-0.25 (-1.14%)

05:27
09/22/17
09/22
05:27
09/22/17
05:27
Recommendations
Ascendis Pharma, Versartis analyst commentary  »

Versartis failure bodes…

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

VSAR

Versartis

$21.60

-0.25 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDX

Becton Dickinson

$191.56

-2.44 (-1.26%)

, BCR

C.R. Bard

$317.37

-1.19 (-0.37%)

05:20
09/22/17
09/22
05:20
09/22/17
05:20
Initiation
Becton Dickinson, C.R. Bard initiated  »

Becton Dickinson…

BDX

Becton Dickinson

$191.56

-2.44 (-1.26%)

BCR

C.R. Bard

$317.37

-1.19 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MB

Mindbody

$24.85

0.05 (0.20%)

05:16
09/22/17
09/22
05:16
09/22/17
05:16
Upgrade
Mindbody rating change  »

Mindbody upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPN

Global Payments

$96.34

0.72 (0.75%)

05:14
09/22/17
09/22
05:14
09/22/17
05:14
Initiation
Global Payments initiated  »

Global Payments initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

RMBS

Rambus

$13.34

-0.01 (-0.07%)

05:10
09/22/17
09/22
05:10
09/22/17
05:10
Downgrade
Rambus rating change  »

Rambus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

EADSY

Airbus

$23.07

0.78 (3.50%)

05:08
09/22/17
09/22
05:08
09/22/17
05:08
Downgrade
Airbus rating change  »

Airbus downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVRA

Savara

$9.47

0.63 (7.13%)

05:06
09/22/17
09/22
05:06
09/22/17
05:06
Initiation
Savara initiated  »

Savara initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANSS

Ansys

$120.82

-2.17 (-1.76%)

05:03
09/22/17
09/22
05:03
09/22/17
05:03
Initiation
Ansys initiated  »

Ansys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 07

    Nov

VSAR

Versartis

$21.60

-0.25 (-1.14%)

05:00
09/22/17
09/22
05:00
09/22/17
05:00
Downgrade
Versartis rating change  »

Versartis downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEG

PSEG

$46.22

0.99 (2.19%)

04:58
09/22/17
09/22
04:58
09/22/17
04:58
Upgrade
PSEG rating change  »

PSEG upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 05

    Nov

04:55
09/22/17
09/22
04:55
09/22/17
04:55
Conference/Events
DA Davidson engineering analyst holds an analyst/industry conference call »

Engineering &…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.